Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

The plant of Nanolek is about to launch production of the third Covivac vaccine

Nanolek uses a traditional technology to produce this vaccine containing an inactivated virus that triggers a potent immune response.

Tatyana Golikova: Russia should minimize imports of medicines

Russia should minimize its dependence on imports of ready-made medicines and pharmaceutical substances, Russian Deputy Prime Minister Tatyana Golikova said on Thursday. /TASS/ "In 2020,...

Egyptian company SOLYPHAR will build a pharmaceutical company in Uzbekistan

It is envisaged to implement the project in three stages from 2021 to 2024, the amount of investment from the company "SOLYPHAR" will be more than 20 million US dollars, in accordance to the international GMP standards.

ROSATOM to supply Brazil with promising isotopes needed in Nuclear Medicine

Isotope JSC (a part of Rusatom Healthcare JSC, Rosatom’s radiation technologies integrator) has signed a five-year contract with Brazil’s Nuclear and Energy Research Institute...

R-Pharm announces the signing of a distribution agreement with PHC Europe B.V.

Etten-Leur, Tokyo, Moscow, June 9, 2021. R-Pharm Group announces the signing of a distribution agreement with PHC Europe B.V., one of the largest suppliers...

FDA Approves Pfizer’s Pneumococcal 20-valent Conjugate Vaccine For Adults

The U.S. Food and Drug Administration has approved Pfizer Inc.'s (PFE) PREVNAR 20 or Pneumococcal 20-valent Conjugate Vaccine for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae or pneumococcus serotypes in the vaccine in adults ages 18 years and older.
spot_img

Expert Articles

spot_img